These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11287771)

  • 1. Linear growth of low-dose cyclosporin A therapy in children with steroid-dependent nephrotic syndrome.
    Kano K; Nishikura K; Hoshi M; Yamada Y; Arisaka O
    Nephron; 2001 Mar; 87(3):293-4. PubMed ID: 11287771
    [No Abstract]   [Full Text] [Related]  

  • 2. [Growth retardation in children with frequent relapsing nephrotic syndrome on steroid--improvement of height velocity after administration of immunosuppressive agent].
    Kitamura M
    Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):117-24. PubMed ID: 1588763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
    Simmonds J; Grundy N; Trompeter R; Tullus K
    Arch Dis Child; 2010 Feb; 95(2):146-9. PubMed ID: 20172895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of linear growth of body height in children with nephrotic syndrome.
    Hung YT; Yang LY
    J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term linear growth of children with severe steroid-responsive nephrotic syndrome.
    Emma F; Sesto A; Rizzoni G
    Pediatr Nephrol; 2003 Aug; 18(8):783-8. PubMed ID: 12811653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Catch-up" growth in steroid dependent dermatomyositis treated with cyclosporin-A.
    Hamill G; Saunders C; Heckmatt J; Dubowitz V; Stanhope R
    Eur J Med; 1992 Apr; 1(1):16-8. PubMed ID: 1341971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.
    El-Husseini A; El-Basuony F; Mahmoud I; Donia A; Sheashaa H; Sabry A; Hassan N; Sayed-Ahmad N; Sobh M
    Eur J Clin Pharmacol; 2006 Jan; 62(1):3-8. PubMed ID: 16374637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final height in children with steroid-sensitive nephrotic syndrome.
    Motoyama O; Iitaka K
    Pediatr Int; 2007 Oct; 49(5):623-5. PubMed ID: 17875088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Height attainment in children with steroid-responsive nephrotic syndrome.
    Foote KD; Brocklebank JT; Meadow SR
    Lancet; 1985 Oct; 2(8461):917-9. PubMed ID: 2865420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panniculitis associated with steroid use.
    Bagga A; Sethi SK; Sharma A
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):539-41. PubMed ID: 20427888
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of rituximab on anthropometric indices among childhood steroid-dependent nephrotic syndromes.
    Sinha R; Banerjee S; Mukherjee A; Akhtar S; Pradhan S
    Arch Dis Child; 2021 Mar; 106(3):283-285. PubMed ID: 32086234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth in children with nephrotic syndrome.
    Tsau YK; Chen CH; Lee PI
    Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):900-6. PubMed ID: 2621431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and endocrine function in steroid sensitive nephrotic syndrome.
    Rees L; Greene SA; Adlard P; Jones J; Haycock GB; Rigden SP; Preece M; Chantler C
    Arch Dis Child; 1988 May; 63(5):484-90. PubMed ID: 3133989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA; Esezobor CI; Lesi FE
    Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
    Hino S; Takemura T; Okada M; Murakami K; Yagi K; Fukushima K; Yoshioka K
    Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J; Ehrich JH; Querfeld U
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose daily treatment with cyclosporin A for relapsing nephrotic syndrome: report of a case showing poor response.
    Tanaka H; Tsugawa K; Tsuruga K; Shimada J; Suzuki K; Ito E
    Clin Nephrol; 2006 Sep; 66(3):219-20. PubMed ID: 16995347
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicity.
    Kano K; Yamada Y; Shiraiwa T; Shimizu A; Nishikura K; Arisaka O; Tomita S; Ueda Y
    Nephrology (Carlton); 2004 Dec; 9(6):414-7. PubMed ID: 15663646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome.
    Tanaka H; Nakahata T; Ito E
    Pediatr Nephrol; 2004 Sep; 19(9):1055-8. PubMed ID: 15160285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.